Literature DB >> 27033070

Detecting PTEN and PI3K Signaling in Brain.

Guo Zhu1, Suzanne J Baker2.   

Abstract

The central nervous system is comprised of multiple cell types including neurons, glia, and other supporting cells that may differ dramatically in levels of signaling pathway activation. Immunohistochemistry in conjunction with drug interference are powerful tools that allow evaluation of signaling pathways in different cell types of the mouse central nervous system in vivo. Here we provide detailed protocols for immunohistochemistry to evaluate three essential components in the PI3K pathway in mouse brain: Pten, p-Akt, and p-4ebp1, and for rapamycin treatment to modulate mTOR signaling in vivo.

Entities:  

Keywords:  Immunohistochemistry; PI3K; PTEN; Rapamycin; p-4EBP1; p-AKT

Mesh:

Substances:

Year:  2016        PMID: 27033070      PMCID: PMC4857604          DOI: 10.1007/978-1-4939-3299-3_5

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  18 in total

1.  Phosphatase and tensin homologue (PTEN) regulates synaptic plasticity independently of its effect on neuronal morphology and migration.

Authors:  Margaret Sperow; Raymond B Berry; Ildar T Bayazitov; Guo Zhu; Suzanne J Baker; Stanislav S Zakharenko
Journal:  J Physiol       Date:  2011-12-06       Impact factor: 5.182

2.  Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex.

Authors:  D D Sarbassov; David A Guertin; Siraj M Ali; David M Sabatini
Journal:  Science       Date:  2005-02-18       Impact factor: 47.728

3.  Pten deletion causes mTorc1-dependent ectopic neuroblast differentiation without causing uniform migration defects.

Authors:  Guo Zhu; Lionel M L Chow; Ildar T Bayazitov; Yiai Tong; Richard J Gilbertson; Stanislav S Zakharenko; David J Solecki; Suzanne J Baker
Journal:  Development       Date:  2012-08-08       Impact factor: 6.868

4.  Turnover of the active fraction of IRS1 involves raptor-mTOR- and S6K1-dependent serine phosphorylation in cell culture models of tuberous sclerosis.

Authors:  O Jameel Shah; Tony Hunter
Journal:  Mol Cell Biol       Date:  2006-09       Impact factor: 4.272

5.  Deletion of Pten in mouse brain causes seizures, ataxia and defects in soma size resembling Lhermitte-Duclos disease.

Authors:  S A Backman; V Stambolic; A Suzuki; J Haight; A Elia; J Pretorius; M S Tsao; P Shannon; B Bolon; G O Ivy; T W Mak
Journal:  Nat Genet       Date:  2001-12       Impact factor: 38.330

6.  Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB.

Authors:  Dos D Sarbassov; Siraj M Ali; Shomit Sengupta; Joon-Ho Sheen; Peggy P Hsu; Alex F Bagley; Andrew L Markhard; David M Sabatini
Journal:  Mol Cell       Date:  2006-04-06       Impact factor: 17.970

7.  Cell type specificity of PI3K signaling in Pdk1- and Pten-deficient brains.

Authors:  Nader Chalhoub; Guo Zhu; Xiaoyan Zhu; Suzanne J Baker
Journal:  Genes Dev       Date:  2009-07-15       Impact factor: 11.361

Review 8.  PTEN and the PI3-kinase pathway in cancer.

Authors:  Nader Chalhoub; Suzanne J Baker
Journal:  Annu Rev Pathol       Date:  2009       Impact factor: 23.472

9.  mTor is required for hypertrophy of Pten-deficient neuronal soma in vivo.

Authors:  Chang-Hyuk Kwon; Xiaoyan Zhu; Junyuan Zhang; Suzanne J Baker
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-08       Impact factor: 11.205

Review 10.  Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress.

Authors:  Shomit Sengupta; Timothy R Peterson; David M Sabatini
Journal:  Mol Cell       Date:  2010-10-22       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.